Skip to main content

Table 3 Prevalence of co-morbidities in non-hypertensive, hypertensive and general populations in the various communities

From: A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria

  

MS

Hyperglycaemia

(≥ 5.6 mmol/l)

Abdominal obesity

$TC> >6.2 mmol

*TG ≥ >1.70 mmol

#HDL

Rural

NHP

5.1

12.2

20.1

4.7

13.7

33.9

 

HP

24.7

23.0

34.4

9.7

22.6

41.3

 

GP

10

14.9

28.2

5.9

15.9

35.8

 

ORs

6.12

2.15

1.49

2.18

1.83

1.37

 

(95% CI)

(3.02 - 12.62)

(1.15 - 3.99)

(0.90 - 2.46)

(0.90 - 5.27)

1.01-3.32

(0.84 - 2.22)

 

p-value

<0.001

0.014

0.12

0.79

0.043

0.20

Semi- urban

       
 

NHP

8.8

9.6

35.2

5.7

23.1

33.8

 

HP

34.7

20.7

57.1

10.8

33.4

27.7

 

GP

18.0

13.6

43.7

7.5

26.7

31.7

 

Ors

(95% CI)

5.52

(3.94 - 7.74)

2.45

(1.69 - 3.57)

2.66

(2.07 - 3.45)

1.99

(1.26 - 3.16)

1.67

(1.26 - 2.21)

0.75

(0.57 - 0.99)

 

p-value

<0.001

<0.001

<0.001

0.003

<0.001

<0.043

Both communities

NHP

7.7

10.4

34.3

5.4

20.4

33.9

 

HP

32.8

21.2

55.0

10.6

31.3

30.4

 

GP

15.9

13.9

41.1

7.1

23.9

32.7

 

Ors

(95% CI)

5.82

(4.30 - 7.89)

2.32

(1.69 - 3.18)

2.35

(1.88 - 2.94)

2.06

(1.37 - 3.09)

1.78

(1.38 - 2.28)

0.85

(0.67 -1.09)

 

p-value

<0.001

<0.001

<0.001

<0.001

<0.001

0.20

  1. Key:$- total cholesterol; *- triglyceride; # - 1.03 mmol/l in males & <1.3 mmol/l in females; NHP non-hypertensive population; HP- population with hypertension; GP- general population; *- p-value: significant